Instructions for Authors

The Journal of Pulmonary Research and Respiratory Medicine is committed to advancing innovation and excellence in respiratory and pulmonary practice through high-quality publication of:
• Original research studies
• Clinical case reports and teaching cases in pulmonary medicine
• Technical and procedural notes
• Review articles and expert perspectives

Our mission is to promote scientific communication and clinical education by disseminating research that improves patient outcomes, strengthens clinical decision-making, and contributes to global pulmonary and respiratory knowledge.

We welcome submissions from:
• Pulmonologists and respiratory specialists
• Critical care and thoracic medicine professionals
• Multidisciplinary clinical and academic teams
• Professionals advancing pulmonary safety and respiratory care standards

2. Article Types

The Journal of Pulmonary Research and Respiratory Medicine publishes a wide range of article types, all subjected to double-blind peer review for quality and relevance.

1. Original Research Articles
   • Clinical, experimental, or translational research in pulmonary and respiratory medicine.
   • Must include methodology, statistical analysis, and interpretation.
   • Word count: 4,000–6,000 words.
2. Clinical Case Reports
   • Unique, rare, or complex respiratory cases with educational significance.
   • Emphasize diagnostic challenges, clinical reasoning, and therapeutic lessons.
   • Word count: 2,000–3,000 words.
3. Review Articles
   • Systematic, narrative, or critical reviews of respiratory disease management, diagnostic techniques, or therapeutic innovation.
   • Should identify practice gaps and propose future directions.
   • Word count: 5,000–8,000 words.
4. Short Communications
   • Early-phase research, pilot studies, or brief observations on pulmonary or respiratory practice.
   • Word count: 1,500–2,500 words.
5. Opinion / Perspective Pieces
   • Expert commentary on innovations, ethical concerns, or controversies in respiratory medicine.
   • Word count: 1,000–2,000 words.
6. Technical Notes / Clinical Techniques
   • Step-by-step descriptions of new, refined, or modified respiratory diagnostic or therapeutic procedures.
   • Emphasis on reproducibility and clinical utility.
   • Word count: 1,500–3,000 words.

3. Manuscript Preparation

Language and Writing Style

• Manuscripts must be in clear, professional English.
• Authors are encouraged to seek editing support if English is not their first language.
• Use of APA 7th Edition for references unless otherwise indicated.
• Define abbreviations at first use; minimize jargon.

Structure

• Title Page: Title, full author names and affiliations, ORCID iDs, corresponding author’s contact info, and a short running title (≤50 characters).
• Abstract: Structured for research articles (Background, Methods, Results, Conclusion); unstructured or omitted for other types. 250–300 words.
• Keywords: 5–7 key terms for indexing.
• Main Text: Organize with clear headings: Introduction, Methods (or Case Description), Results, Discussion, and Conclusion.
• Acknowledgments: Funding, technical assistance, and contributors not qualifying for authorship.
• Conflict of Interest: Disclose all financial or non-financial conflicts.
• Data Availability Statement: Indicate where supporting data can be accessed or justify limitations.

References Style

(Example structure retained; references can be customized to pulmonary medicine.)
• Smith A, Jones R, Patel D, et al. (2019). Advances in the management of chronic obstructive pulmonary disease. Respir Med J. 138(3):517–523.
• Miller RD, Cohen NH. (2021). Pulmonary and Respiratory Medicine. 9th ed. Philadelphia: Elsevier.
• Ware LB, Matthay MA. (2000). The acute respiratory distress syndrome. N Engl J Med. 342(18):1334–1349.

Ethical Compliance

• All clinical or experimental studies must comply with the Declaration of Helsinki and institutional ethical standards.
• Ethical approval and patient consent must be documented in the manuscript.
• Case reports involving identifiable patient information require written patient consent.
• Animal studies must follow internationally accepted animal care guidelines.
• Clinical trials must be registered (e.g., ClinicalTrials.gov) with registration number included.

5. Submission and Peer Review Process

Submission

• Submit manuscripts via the Journal of Pulmonary Research and Respiratory Medicine Online Submission System (Otso Publishers).
• Acceptable file formats: .doc/.docx for manuscripts; .png, .tiff, .eps for figures.
• A cover letter must accompany all submissions and include:
o A statement of originality
o Relevance to pulmonary and respiratory medicine
o Confirmation that the manuscript is not under review elsewhere
• Authors may suggest reviewers but must avoid suggesting collaborators or recent co-authors.

Peer Review

• The Journal of Pulmonary Research and Respiratory Medicine follows a double-blind peer review process.
• Manuscripts are evaluated for clinical relevance, originality, technical rigor, and ethical compliance.
• Editorial decisions: Accept, Minor Revision, Major Revision, or Reject.
• Authors must submit timely, point-by-point responses to reviewer comments.

6. Post-Acceptance Procedures

• Proofs will be sent to the corresponding author for final review.
• Only minor typographical changes will be accepted at proof stage.
• High-resolution figures and supplementary materials must be submitted before publication.
• Authors are required to sign a Publication Agreement granting the journal the right to publish under the open-access license.

7. Open Access Policy & Article Processing Charges (APCs)

• The Journal of Pulmonary Research and Respiratory Medicine operates as a fully open access journal under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
• Articles are freely accessible online upon publication.
• APC: USD $535 per accepted article.
• APCs cover peer review, editorial processing, layout editing, and long-term digital archiving.
• Waivers or discounts may be offered to:

• Authors from low- or middle-income countries
• Early-career professionals or non-funded research

8. Copyright and Licensing

• Authors retain copyright.
• Upon acceptance, authors grant Otso Publishers a license to publish and distribute the work under CC BY 4.0.
• Use of third-party figures, tables, or content requires written permission and attribution.

9. Plagiarism, Redundancy & Scientific Misconduct

• All manuscripts are screened for plagiarism, including self-plagiarism and AI-generated content.
• Duplicate publication or data fabrication will result in rejection and may be reported to appropriate authorities.
• The journal adheres to COPE (Committee on Publication Ethics) best practices.